Compare DAO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAO | AMPH |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2019 | 2014 |
| Metric | DAO | AMPH |
|---|---|---|
| Price | $9.11 | $25.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 132.8K | ★ 368.5K |
| Earning Date | 11-20-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 155.59 | N/A |
| EPS | 0.17 | ★ 2.27 |
| Revenue | ★ $798,421,874.00 | $723,305,000.00 |
| Revenue This Year | $5.23 | $1.35 |
| Revenue Next Year | $13.46 | $5.10 |
| P/E Ratio | $53.15 | ★ $11.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.30 | $20.39 |
| 52 Week High | $11.82 | $45.39 |
| Indicator | DAO | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 42.84 |
| Support Level | $8.81 | $25.22 |
| Resistance Level | $9.90 | $27.84 |
| Average True Range (ATR) | 0.44 | 0.80 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 20.30 | 2.56 |
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.